Review Article - International Journal of Clinical Rheumatology (2023) Volume 18, Issue 6

A cohort research in Taiwan with a community focus looked at the clinical traits of kids with juvenile idiopathic arthritis using the ILAR bracket criteria.

Peter S Sander*

Department of Pediatrics and School of Rehabilitation Sciences, University of Swaziland, Swaziland

*Corresponding Author:
Peter S Sander
Department of Pediatrics and School of Rehabilitation Sciences, University of Swaziland, Swaziland

Received: 01-June-2023, Manuscript No. FMIJCR-23-103573; Editor assigned: 03- June-2023, Pre-QC No. FMIJCR-23-103573 (PQ); Reviewed: 17-June-2023, QC No. FMIJCR-23-103573; Revised: 23-June- 2023, Manuscript No. FMIJCR-23-103573 (R); Published: 30-June-2023, DOI: 10.37532/1758-4272.2023.18(6).150-153



The end of the study was to describe the clinical features of children affected by juvenile idiopathic arthritis (JIA) under the International League of Associations for Rheumatology- deduced bracket criteria in a community- grounded setting.


Successive cases of JIA from defined geographic areas of Taiwan were diagnosed and followed in an experimental cohort from 1995 to 2010. In addition to the clinical and laboratory data needed for the International League of Associations for Rheumatology system, information about the drug and complaint exertion during the study period was also recorded.


Out of 292 children with habitual common pain, 195 were diagnosed as JIA systemic arthritis( 19), oligoarthritis( patient16.4; extended6.7), polyarthritis rheumatoid factor-negative(11.8), polyarthritis rheumatoid factor-positive(4.6), psoriatic arthritis(1.5), enthesitis- related arthritis( period;37.4), and undifferentiated arthritis(2.6). Mortal leukocyte antigen- B27 was positive in82.2 of cases with period. Uveitis was observed in6.7 of cases. Disease- modifyinganti-rheumatic medicines, including birth specifics, were used in73.3 of children during the experimental period. At the last follow- up, 40 of cases endured a continuously active or relapsing course.


Compared with former reports on Western populations, a remarkably high frequence was set up in the period of the Chinese cohort, but a fairly low rate of uveitis. Ongoing complaint exertion was apparent in a substantial number of children. These results handed a good starting point in understanding the epidemiology of this serious complaint in the Chinese population.


Bracket criteria • Juvenile rheumatoid arthritis • Pediatric rheumatic complaint


Juvenile idiopathic arthritis( JIA) isn't a single complaint and comprises — as an “ marquee ” term all habitual arthritis of unknown etiology persisting for at least 6 weeks with a clinical onset before 16 times of age. The complaint diapason spans from tone- limited monoarthritis to ongoing multiple joints destruction, and June involves severe systemic instantiations or sight- hanging uveitis. In order to give a better quality on medical treatment and follow- up, streamlined knowledge of the epidemiology, clinical features, and course of JIA is essential. In the last decade, our study group proposed the clinical features of juvenile rheumatoid arthritis grounded on the American College of Rheumatology system. To find a further homogenous complaint bracket suitable for aetiopathogenetic studies, the International League of Associations for Rheumatology (ILAR) developed a new set of bracket criteria for nonage- onset idiopathic seditious arthritis and called it JIA. The system was revised several times to ameliorate its utility. First proposed in 1994(Santiago criteria) the bracket system was doubly revised in 1997(Durban) 3 and in 2001(Edmonton). The distribution of JIA orders in the Chinese population according to the ILAR system, still, is lacking. In view of this, our end was to describe a cohort of Chinese cases with JIA using the rearmost modification of ILAR bracket criteria. We also intended to emphasize on the clinical instantiations, complaint, and treatment course of JIA in a community- grounded setting [1-5].

Materials and Method

The study was carried out at the pediatric rheumatologic clinic of the Chang Gung Memorial Hospital (CGMH), Kweishan (Taoyuan county, Northern Taiwan), which runs an inpatient community referral clinic for the catchment areas. Every week, 10 – 30 children with rheumatic conditions are examined in the clinic. Although there are several pediatric inpatient and inpatient installations, the primary health care, orthopedic, pediatric, and rheumatology specialists in the catchment areas tend to relate children with habitual common pain to the CGMH. The frequence of JIA in Taiwan in 1999 was3.8 per 100,000 occupants, as preliminarily reported by our study group.


During the period 1995 – 2010, 292 children were suspected of having habitual joint pain (judgments other than JIA were nonspecific arthralgia other connective towel diseases and rheumatic fever (3)). Beginning in January 2002, we began to classify cases according to the ILAR bracket system and followed them in a longitudinal experimental cohort. From August to December 2011, we carried out a final cross-sectional analysis. Several children with loss of follow- up were recalled along with their guardians for the final studyvisit. However, they were communicated by telephone call, If they were unapproachable. The minimum demand to stay included in the follow-up study cohort was two registered visits, and all actors had been followed for at least 18 months. Thirty- six children who had deficient clinical records and couldn't be canvassed were barred. We set up that 195 children satisfied the current ILAR bracket criteria for JIA [6-8].

Detailed clinical biographies during the first time of illness and disquisition results were retrospectively reviewed and collected in standard case record forms. JIA orders were determined grounded on all available information registered at each visit during the study period, and for the maturity of children this was determined independently by two of the authors (J.- L.H. and C.-C.S.). A many disagreement were settled by discussion. Disease onset was defined as the date when the child, according to anamnestic information, fulfilled the criteria of active arthritis or onset of systemic features, not inescapably verified by a croaker. Joints involvement was defined as common lump or limitation in the range of common movement with common pain or tender-heartedness, which persists for at least 6 weeks. Uveitis was diagnosed by an ophthalmologist. Absolution status was determined according to the primary criteria published by Wallace. Circumstance of relapse was registered if there's a presence of absolution off drug for further than 1 time, followed by new ages of exertion. Mortal leukocyte antigen (HLA) - B27 antigen (by microlymphocytotoxicity assay or direct immunocytometry) was anatomized at onset. Antinuclear antibodies (Corpus; by circular immunofluorescence assay) and rheumatoid factor (RF; by nephelometry) were anatomized doubly, at least 3 months piecemeal. RF values ≥ 40 IU/ mL or titers of Corpus ≥ 140 were classified as positive. The study was approved by the Institutional Review Board of CGMH. All cases were informed about our exploration [9,10].

Statistical analyses

Descriptive statistics were shown as the standard (interquartile range (iqr)) for nonstop variables and as probabilities for categorical variables. Categorical variables were anatomized with Fisher’s exact test and ki-square test when applicable. A p value<0.05 was considered significant. Statistical analyses were performed using the SPSS software package for windows( interpretation17.0; SPSS, Chicago, IL, USA).


Characteristics of cases

Of the 195 included children classified as having JIA, 148(75.9) had a follow- up 5 times or further after the date of opinion (standard8.7 times, iqr6.0 –12.5). Of the final enrollments, 150(77.0) were clinic visits and 45 were telephone interviews. Telephone interviews were substantially performed for actors when clinical follow- up had been transferred from the pediatric rheumatologist either to primary health care due to absolution or to adult care because of age. The distribution of ILAR orders is shown in. Enteritis- related arthritis (period) was the single largest order (37.4), followed by oligoarthritis (23.1) and systemic arthritis (19.0). Table 1 shows the clinical features related to the ILAR bracket system at the final study visit. Of the 45 children with oligoarticular onset, 13(28.9) had an extended course after the first 6 months of complaint. Another two children had changed JIA orders from oligoarthritis to period due to sacroiliac common involvement. Boys outnumbered girls at a rate of1.211. Between the onset of complaint and the opinion of arthritis by a croaker, there was a median time interval of 120 days (iqr 44 – 365). The median age at onset of this series was 9.5 times (iqr6.3 –12.0).


In this study, 97 of Chinese children with habitual idiopathic seditious arthritis were classified into separate JIA orders using the rearmost revised ILAR bracket system (Edmonton, 2001). This success was in line with what had been achieved before (87 – 95) by investigators in other regions or countries. With registration of a large number of children with JIA in a community setting, this is presumably the first report of a methodical evaluation of the current ILAR system in Taiwan. The results were analogous with those attained in India and Turkey. Still, compared with former reports in Western countries, the cohort in Taiwan showed a relatively different phenotypic diapason of JIA. Period (frequence, 37 in our studyvs. 7 – 13 in Western countries was the most common JIA order in Chinese children. In our study, because period generally has its onset in late nonage or nonage, the age of onset of illness appeared comparatively advanced with a peak distributed over the pubertal stage. Also, this reason June incompletely explain why boys outnumber girls in the frequence of JIA.

The knee, ankle, and wrist were the most constantly involved joints in this series, whereas the small joints of the hands and bases were affected substantially in cases with the polyarthritis and period. The reported frequence of optical involvement varies worldwide 10 in the United States, 12 in Germany and 20 in the Nordic countries. The relative occasional frequence in our study was in line with rates attained in other Asian countries (India, Korea, and Japan).

The current cohort study heightens the conception of JIA as a habitual complaint showing that a substantial number of children with JIA experience continuously ongoing complaint exertion or a relapsing course, which extends into majority. Analogous results were shown using the recently developed absolution criteria in retrospective studies for select orders of JIA by Wallace. The use of birth agents in pediatric rheumatology represents the morning of a new period in medical treatment of JIA. The major thing of ultramodern treatment in JIA is switched from control of complaint to absolution of complaint with or without drug. suggestions and blessings have been widened as efficacity and safety data on birth agents in children have surfaced. Because etanercept was introduced at about the same time our study started, the use of birth specifics in12.8 of our cohort during complaint course reflects the steadily adding use during the once decade and might have been advanced under Taiwan’s National Health Insurance program. In addition to the birth agents, non-steroidalanti-inflammatory medicines remain the dependence of medical treatment for JIA, followed byintra-articular corticosteroid injection and complaint- modifyinganti-rheumatic medicines. The timing and choice of these medicines differed from the report described by Cron etal. 26 As a whole, piecemeal from non-steroidalanti-inflammatory medicines and steroids, methotrexate was the most common treatment; sulfasalazine, azathioprine, and cyclosporine were reserved for children who didn't respond to a less aggressive remedy. Non etheless, in a review of literature, sulfasalazine and azathioprine were effective and wellpermitted in Chinese children with JIA.

Conflicts of Interest





  1. Cranshaw I, Gikas P, Fisher C. Clinical outcomes of extra- thoracic solitary fibrous tumours. Eur J Surg Oncol. 35(9), 994-998 (2009).
  2. Indexed at, Google Scholar, Crossref

  3. Vallat-Decouvelaere AV, Dry SM, Fletcher CD et al. Atypical and malignant solitary fibrous tumors in extrathoracic locations, evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol. 22(12), 1501-1511 (1998).
  4. Indexed at, Google Scholar, Crossref

  5. Gold JS, Antonescu CR, Hajdu C et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer. 94(4), 1057-1068 (2002).
  6. Indexed at, Google Scholar, Crossref

  7. Kayani B, Sharma A, Sewell MD, et al. A Review of the Surgical Management of Extrathoracic Solitary Fibrous Tumors. Am J Clin Oncol. 41(7), 687-694 (2018).
  8. Indexed at, Google Scholar, Crossref

  9. Demicco EG, Park MS, Araujo DM et al. Solitary fibrous tumor, a clinic pathological study of 110 cases and proposed risk assessment model. Mod Pathol. 25(9), 1298-1306 (2012).
  10. Indexed at, Google Scholar, Crossref

  11. Baldi GG, Stacchiotti S, Mauro V et al. Solitary fibrous tumor of all sites, outcome of late recurrences in 14 patients. Clin Sarcoma Res. 3, 4 (2013).
  12. Indexed at, Google Scholar, Crossref

  13. Park MS, Patel SR, Ludwig JA et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer.  117(21), 4939-4947 (2011).
  14. Indexed at, Google Scholar, Crossref

  15. Choi H, Charnsangavej C, Faria SC et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol. 25(13), 1753-1759 (2007).
  16. Indexed at, Google Scholar, Crossref

  17. Roughley PJ, Mort JS. The role of aggrecan in normal and osteoarthritic cartilage. J Exp Orthop. 1(1), 8 (2014).
  18. Indexed at, Google Scholar, Crossref

  19. Chiusaroli R, Piepoli T, Zanelli T et al. Experimental pharmacology of glucosamine sulfate. Int J Rheumatol.  2011, 939265 (2011).
  20. Indexed at, Google Scholar, Crossref

Awards Nomination 20+ Million Readerbase

Select your language of interest to view the total content in your interested language

Google Scholar citation report
Citations : 5529

International Journal of Clinical Rheumatology received 5529 citations as per Google Scholar report

International Journal of Clinical Rheumatology peer review process verified at publons

Indexed In